Literature DB >> 28632310

Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Pathology Standards and Datasets.

Gerald Langman1, Maurice Loughrey2, Neil Shepherd3, Philip Quirke4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28632310     DOI： 10.1111/codi.13708

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN： 1462-8910            Impact factor:   3.788


× No keyword cloud information.
  4 in total

1.  Metabolic syndrome is a predictor of all site and liver-specific recurrence following primary resection of colorectal cancer: Prospective cohort study of 1006 patients.

Authors:  Rahul Bhome; Nadia Peppa; Shoura Karar; Declan McDonnell; Alex Mirnezami; Zaed Hamady
Journal:  Eur J Surg Oncol       Date:  2021-01-07       Impact factor: 4.424

2.  CRC COVID: Colorectal cancer services during COVID-19 pandemic. Study protocol for service evaluation.

Authors:  Alona Courtney; Ann-Marie Howell; Najib Daulatzai; Nicos Savva; Oliver Warren; Sarah Mills; Shahnawaz Rasheed; Goel Milind; Nicholas Tekkis; Matthew Gardiner; Tinglong Dai; Bashar Safar; Jonathan E Efron; Ara Darzi; Paris Tekkis; Christos Kontovounisios
Journal:  Int J Surg Protoc       Date:  2020-08-11

3.  The effect of pericolic lymph nodes metastasis beyond 10 cm proximal to the tumor on patients with rectal cancer.

Authors:  Xuyang Yang; Erliang Zheng; Lina Ye; Chaoyang Gu; Tao Hu; Dan Jiang; Du He; Bing Wu; Qinbing Wu; Tinghan Yang; Mingtian Wei; Wenjian Meng; Xiangbing Deng; Ziqiang Wang; Zongguang Zhou
Journal:  BMC Cancer       Date:  2020-06-19       Impact factor: 4.430

4.  Transanal total mesorectal excision for low rectal cancer: a case-matched study comparing TaTME versus standard laparoscopic TME.

Authors:  Mateusz Rubinkiewicz; Michał Nowakowski; Mateusz Wierdak; Magdalena Mizera; Marcin Dembiński; Magdalena Pisarska; Piotr Major; Piotr Małczak; Andrzej Budzyński; Michał Pędziwiatr
Journal:  Cancer Manag Res       Date:  2018-11-01       Impact factor: 3.989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.